In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition

Abstract Introduction Circulating tumor DNA (ctDNA) holds promise for guiding immune checkpoint inhibitor (ICI) therapy and stratifying responders from non-responders. While tumor-informed ctDNA detection approaches are sensitive and mutation-inclusive, they require tumor tissue, which limits applic...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Isabel Heidrich, Charlotte Rautmann, Cedric Ly, Robin Khatri, Julian Kött, Glenn Geidel, Alessandra Rünger, Antje Andreas, Inga Hansen-Abeck, Finn Abeck, Anne Menz, Stefan Bonn, Stefan W. Schneider, Daniel J. Smit, Christoffer Gebhardt, Klaus Pantel
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	BMC 2025-07-01
श्रृंखला:	Journal of Experimental & Clinical Cancer Research
विषय:	CtDNA Liquid Biopsy Melanoma BRAF NRAS KRAS
ऑनलाइन पहुंच:	https://doi.org/10.1186/s13046-025-03457-w
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!